Advisors Preferred’s Phibro Animal Health PAHC Stock Holding History

Advisors Preferred’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,998	Closed	-$2.93M	–	292
2026 Q1	$2.93M	Buy	+52,998	New	+$2.52M	0.43%	54
2025 Q4	–	Sell	-96,886	Closed	-$3.95M	–	289
2025 Q3	$3.95M	Buy	+96,886	New	+$3.2M	0.58%	36
2016 Q4	–	Sell	-7,828	Closed	-$213K	–	243
2016 Q3	$213K	Buy	+7,828	New	+$177K	0.1%	71

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Advisors Preferred's PAHC Position: Q2 2026 in Review

Advisors Preferred sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 52,998 shares — an estimated $2.93M sold.

Advisors Preferred first reported a position in PAHC in Q3 2016 and held it in 3 quarters. The position peaked at $3.95M in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Advisors Preferred reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
Advisors Preferred sold 52,998 Phibro Animal Health shares in Q2 2026, an estimated $2.93M.
Advisors Preferred first reported a position in Phibro Animal Health in Q3 2016 and held it in 3 quarters.
Advisors Preferred's Phibro Animal Health position peaked at $3.95M in Q3 2025.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.